alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

                                CERTIFICATIONS

I, William Tay, certify that:

1. I have reviewed this quarterly Report on Form 10-QSB of Trivest Acquisition
Corp.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The small business issuer's other certifying officers and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer
and have:

   (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this quarterly report
is being prepared;

   (b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

   (c) Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the small business
issuer's internal control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of the small business issuer's board of directors (or persons
performing the equivalent functions):

   (a) All significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

   (b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.


Date: May 7, 2008

TRIVEST ACQUISITION CORP.


/s/ William Tay
-------------------------------
William Tay, President and CEO
(Principal Executive and Financial Officer)
Exhibit 32
 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
  1.
    
    the Report fully complies with the requirements of Sections 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 2.
    
    the information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 Date: May 11, 2009
    /s/ Michael D. DevlinMichael D. DevlinPresident and Chief Executive OfficerDate: May 11, 2009
    /s/ Guy HackneyGuy HackneySenior Vice President and Chief Financial Officer
EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 (AS ADOPTED

PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002)



In connection with the annual report of Stellar Pharmaceuticals Inc. (the Company) on Form 10-KSB for the fiscal year ended December 31, 2007as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Janice Clarke, Chief Financial Officer, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and,



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.



Date:  March 31, 2008



| |                              
| | -----------------------------
| | /s/ Janice Clarke            
| | Janice Clarke                
| | Chief Financial Officer      
| | (Principle Financial Officer)



A certification furnished pursuant to this Item will not be deemed filed for purposes of section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the small business issuer specifically incorporates it by reference.
H. Res. 1051 

In the House of Representatives, U. S., 

February 3, 2010. 

Resolved, That at any time after the adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule 

XVIII, declare the House resolved into the Committee of the 

Whole House on the state of the Union for consideration of 

the bill (H.R. 4061) to advance cybersecurity research, development, and technical standards, and for other purposes. The 

first reading of the bill shall be dispensed with. All points of 

order against consideration of the bill are waived except those 

arising under clause 9 or 10 of rule XXI. General debate 

shall be confined to the bill and shall not exceed one hour 

equally divided and controlled by the chair and ranking minority member of the Committee on Science and Technology. 

After general debate the bill shall be considered for amendment under the five-minute rule. It shall be in order to consider as an original bill for the purpose of amendment under 

the five-minute rule the amendment in the nature of a substitute recommended by the Committee on Science and Technology now printed in the bill. The committee amendment in 
2 

•HRES 1051 EH 

the nature of a substitute shall be considered as read. All 

points of order against the committee amendment in the nature of a substitute are waived except those arising under 

clause 10 of rule XXI. Notwithstanding clause 11 of rule 

XVIII, no amendment to the committee amendment in the 

nature of a substitute shall be in order except those printed 

in the report of the Committee on Rules accompanying this 

resolution. Each such amendment may be offered only in the 

order printed in the report, may be offered only by a Member 

designated in the report, shall be considered as read, shall be 

debatable for the time specified in the report equally divided 

and controlled by the proponent and an opponent, shall not 

be subject to amendment, and shall not be subject to a demand for division of the question. All points of order against 

such amendments are waived except those arising under 

clause 9 or 10 of rule XXI. At the conclusion of consideration 

of the bill for amendment the Committee shall rise and report 

the bill to the House with such amendments as may have 

been adopted. The previous question shall be considered as 

ordered on the bill and amendments thereto to final passage 

without intervening motion except one motion to recommit 

with or without instructions. 

SEC. 2. The Chair may entertain a motion that the 

Committee rise only if offered by the chair of the Committee 

on Science and Technology or his designee. The Chair may 
3 

•HRES 1051 EH 

not entertain a motion to strike out the enacting words of the 

bill (as described in clause 9 of rule XVIII). 

Attest: 

Clerk.
IV 

111TH CONGRESS 

2D SESSION H. RES. 1030 

Congratulating Messiah College men’s and women’s soccer teams on winning 

the 2009 NCAA Division III national championships. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 21, 2010 

Mr. PLATTS submitted the following resolution; which was referred to the 

Committee on Education and Labor 

RESOLUTION 

Congratulating Messiah College men’s and women’s soccer 

teams on winning the 2009 NCAA Division III national 

championships. 

Whereas Messiah College men’s and women’s soccer teams 

won the 2009 NCAA Division III championships on December 5, 2009, against Calvin College and Washington 

University-St. Louis; 

Whereas the 2009 championship was the seventh national 

championship for Messiah College men’s soccer team 

since 2000 and the third national championship for the 

women’s team since 2000; 

Whereas Messiah College is the only college in the NCAA to 

win both the men’s and women’s soccer national championship in the same year; 


smartinez on DSKB9S0YB1PROD with BILLS
2 

•HRES 1030 IH 

Whereas Messiah College is a Christian liberal arts college 

that was founded in 1909 and is located in Grantham, 

Pennsylvania; 

Whereas Messiah College has 22 intercollegiate athletic teams 

that have won 11 NCAA national championships; and 

Whereas Messiah College encourages athletes to develop their 

athletic excellence and to develop character: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) congratulates Messiah College men’s and 

3 women’s soccer teams on winning the 2009 NCAA 

4 Division III national championships; and 

5 (2) recognizes Messiah College for excellence in 

6 academics, athletics, and character. 

Æ 


smartinez on DSKB9S0YB1PROD with BILLS
Mr. Christopher J. Kirkpatrick
December 9, 2019
Page 5
EXHIBIT C

Marked Copy of Amended tpSEF Fee Schedule

[FOIA Confidential Treatment Requested]


Mr. Christopher J. Kirkpatrick
December 9, 2019
Page 4
EXHIBIT B

Amended tpSEF Fee Schedule

[FOIA Confidential Treatment Requested]


(> tullett prebon

tpSEF Inc.

101 Hudson Street
Jersey City

NJ 07302

USA

tel +1201 $57 5000
fax. +1201 557 5995

web www:tullettprebon.com

December 9, 2019
Submitted via the CFTC Portal

Mr. Christopher J. Kirkpatrick

Secretary of the Commission

Office of the Secretariat

Commodity Futures Trading Commission
Three Lafayette Centre

1155 21" Street, N.W.

Washington, D.C. 20581

Re: — {pSEF Inc. — Regulation 40.6(a) Rule Certification — Notification of Amendments to
tpSEF Fee Schedu\2 (tpSEF Submission #19-01F)

To Whom It May Concern:

Pursuant to Section Se(c) of the Commodity Exchange Act, as amended (the “Act”), and Section 40.6(a)
of the regulations of the Commodity Futures Trading Commission (the “Commission”), tpSEF Inc.
(‘tpSEF”), a registered swap execution facility, hereby notifies the Commission that it wishes to amend
its fee schedule (“Fee Schedule”) as described in Exhibit A, The amended Fee Schedule will become
effective on December 23, 2019.

Pursuant to Commission Regulation 40.6, this submission includes:

(i) A concise explanation and analysis of the amended Fee Schedule and its compliance with
applicable provisions of the Act, attached as Exhibit A;

(ii) A clean copy of the amended Fee Schedule, attached as Exhibit B; and

(iii) A copy of the amended Fee Schedule marked to show changes to the version currently in
effect (the “Marked Fee Schedule”), attached as Exhibit C.

tpSEF hereby certifies that (i) the amendment complies with the requirements of the Act and Commission
regulations thereunder, and (ji) a notice and copy of this submission is being concurrently posted on
tpSEF’s website. tpSEF is not aware of any substantive opposing views expressed with respect to this
filing.

ACTIVE 251404810


» tullett prebon

Mr. Christopher J. Kirkpatrick
December 9, 2019
Page 2

tpSEF is separately filing with the Assistant Secretary of the Commission for FOI, Privacy and Sunshine
Acts Compliance, pursuant to Commission Regulation 145.9, a petition for confidential treatment of (i)
the amended Fee Schedule attached as Exhibit B, (ii) the Marked Fee Schedule attached as Exhibit C and
(iii) the explanation and analysis of the amendments to the Fee Schedule attached as Exhibit A. A copy of
the FOJA Confidential Treatment Request is included with this submission.

Please contact Brian D, Donnelly, Chief Compliance Officer, at (201) 984-6956 or by email at
bddonnelly@tullettprebon.com with any questions regarding this matter.

Very truly yours,

tpSEF Inc.

By:

Name: Brian Donnelly
Title: Chief Compliance Officer
Date: December 9, 2019

Enclosures

ce: CFTC Division of Market Oversight (dmosubmissions@cftc.gov)
Nancy Markowitz, CFTC (nmarkowitz@cftc.gov)


Mr. Christopher J, Kirkpatrick
December 9, 2019
Page 3

EXHIBIT A

Explanation of Amendments to tpSEF Fee Schedule

[FOIA Confidential Treatment Requested]
#### UNITED STATES of America, Plaintiff-Appellee v. Francisco Antonio MENDEZ, Defendant-Appellant.

No. 09-40693

Conference Calendar.

United States Court of Appeals, Fifth Circuit.

June 22, 2010.

James Lee Turner, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

Marjorie A. Meyers, Federal Public Defender, Houston, TX, for Defendant-Appellant.

*407Before JOLLY, STEWART, and OWEN, Circuit Judges.

PER CURIAM: *

The Federal Public Defender appointed to represent Francisco Antonio Mendez has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Mendez has not filed a response. Our independent review of the record and counsel’s brief discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
Exhibit 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HL Ventures Inc. (the "Company") on
Form 10-Q for the period ending January 31, 2008 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Deniz Hassan,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
14th day of March, 2008.


/s/ Deniz Hassan
---------------------------
Chief Financial Officer
Dismissed and Opinion Filed December 10, 2020

In The

Court of Appeals

Fifth District of Texas at Dallas

No. 05-20-00715-CV

TRI PHAM, Appellant

V.

MITRA MAHMOUDI, Appellee

On Appeal from the County Court at Law No. 5

Dallas County, Texas

Trial Court Cause No. CC-20-01961-E

MEMORANDUM OPINION

Before Justices Whitehill, Schenck, and Browning

Opinion by Justice Schenck

The filing fee, docketing statement, and clerk’s record in this case are past 

due. By postcard dated August 3, 2020, we notified appellant the $205 filing fee 

was due. We directed appellant to remit the filing fee within ten days and expressly 

cautioned appellant that failure to do so would result in dismissal of the appeal. Also

by postcard dated August 3, 2020, we informed appellant the docketing statement in 

this case was due. We cautioned appellant that failure to file the docketing statement 

within ten days might result in the dismissal of this appeal without further notice. 

By letter dated November 2, 2020, we informed appellant the clerk’s record had not 
–2–

been filed because appellant had not paid for the clerk’s record. We directed 

appellant to provide, within ten days, (1) verification of payment or arrangements to 

pay for the clerk’s record, or (2) written documentation that appellant had been found 

entitled to proceed without payment of costs. We cautioned appellant that failure to 

do so would result in the dismissal of this appeal without further notice. To date, 

appellant has not paid the filing fee, filed the docketing statement, provided the 

required documentation, or otherwise corresponded with the Court regarding the 

status of this appeal.

Accordingly, we dismiss this appeal. See TEX. R. APP. P. 37.3(b); 42.3(b),

(c).

200715F.P05

/David J. Schenck/

DAVID J. SCHENCK

JUSTICE
–3–

Court of Appeals

Fifth District of Texas at Dallas

JUDGMENT

TRI PHAM, Appellant

No. 05-20-00715-CV V.

MITRA MAHMOUDI, Appellee

On Appeal from the County Court at 

Law No. 5, Dallas County, Texas

Trial Court Cause No. CC-20-01961-

E.

Opinion delivered by Justice 

Schenck. Justices Whitehill and 

Browning participating.

In accordance with this Court’s opinion of this date, this appeal is 

DISMISSED.

It is ORDERED that appellee MITRA MAHMOUDI recover her costs of 

this appeal from appellant TRI PHAM.

Judgment entered this 10th day of December, 2020.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1069 Engrossed in House (EH)]

H. Res. 1069

                In the House of Representatives, U. S.,

                                                         March 9, 2010.
Whereas breakthroughs in scientific research are the building blocks of a 
        productive, competitive, and healthy society;
Whereas the Nobel Prize is a prestigious international award administered 
        annually by the Nobel Foundation in Stockholm, Sweden, and has since 
        1901 recognized the world's most outstanding achievements in physics;
Whereas, on December 10, 2009, in Stockholm, Sweden, Willard S. Boyle and George 
        E. Smith from Bell Laboratories in Murray Hill, New Jersey, were awarded 
        the Nobel prize for physics for their invention of an imaging 
        semiconductor circuit, the charge-coupled devise (CCD), in addition to 
        Charles K. Kao from Standard Telecommunication Laboratories in Harlow, 
        United Kingdom, and the Chinese University of Hong Kong in Hong Kong, 
        China, for his work concerning the transmission of light in fibers for 
        optical communication;
Whereas Bell Laboratories in Murray Hill, New Jersey, is an internationally 
        renowned research organization founded in 1925 by the American Telephone 
        & Telegraph company (AT&T);
Whereas a total of seven Nobel Prizes for physics have been awarded for work 
        completed at Bell Laboratories;
Whereas work at Bell Laboratories has led to the invention or advancement of 
        such groundbreaking technologies as the transistor, photovoltaic cells, 
        the laser, the UNIX operating system, and the CCD sensor;
Whereas scientific leadership in the United States is made possible by robust 
        investments in scientific research programs in both the public and 
        private sectors;
Whereas continued support of science research programs is indispensable to 
        maintaining the Nation's position as the global leader in technology and 
        innovation; and
Whereas the accomplishments of these scientists are significant achievements in 
        the field of scientific research and further promote the United States 
        among the world leaders in science: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) congratulates Willard S. Boyle and George E. Smith for being 
        awarded the Nobel Prize in physics; and
            (2) recognizes Bell Laboratories in Murray Hill, New Jersey, as a 
        contributor to leadership in scientific research and innovation in the 
        United States.
            Attest:

                                                                          Clerk.
```
EXHIBIT 32.2




Certification of Executive Vice President and Chief Operating Officer


Pursuant to 18 U.S.C. Section 1350, As Adopted


Pursuant to Section 906 of Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report on Form 10-Q of Danvers Bancorp, Inc. (the “Company”) for the three and nine months ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I hereby certify, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and





2.
The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company as of, and for, the period covered by the Report.





This statement is authorized to be attached as an exhibit to the Report so that this statement will accompany the Report at such time as the Report is filed with the Securities and Exchange Commission, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.  It is not intended that this statement be deemed to be filed for purposes of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.





Date:           November 10, 2010











/s/
James J. McCarthyJames J. McCarthyExecutive Vice President and Chief Operating Officer
Exhibit 32.1








CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT 0F 2002





In connection with the Amended Quarterly Report of ECO BUILDING PRODUCTS, INC. (the "Company") on Form 10-Q /A for the period ending March 31, 2013 , as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, STEVE CONBOY, President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





/s/ Steve Conboy


Steve Conboy


President


Principal Executive Officer and Principal Financial Officer





August 15 , 2013